Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
Elucidation and pharmacological targeting of tumour checkpoint dependencies

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.04.16
Views: 2705

Dr Andrea Califano - Colombia University Medical Centre, New York, USA

Dr Andrea Califano speaks with ecancertv at AACR 2016 to summarise recent developments in cancer research and advances in checkpoint research.

From past therapies to modern immunotherapy, Dr Califano looks forward to the next potential steps in cancer management; mechanistic targets, tumour checkpoints and cell regulators.

By developing comprehensive models of cell behaviours with which to forecast drug efficacy and identify oncogenic sources, he describes the potential of near-future therapies to single out the root causes of cancer, before they manifest as malignancies.

Dr Califano will also be a keynote speaker at the WIN consortium meeting in Paris and you can hear more on his upcoming talk in this interview with WIN chairman Dr John Mendelsohn.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation